Related Experiment Video
Updated: Apr 15, 2026
Double Labeling Immunofluorescence using Antibodies from the Same Species to Study Host-Pathogen Interactions
Published on: July 10, 2021
Immunofluorescence assay for diagnosis of strongyloidiasis in immunocompromised patients
Maiara Gottardi1, Fabiana M Paula, Marcelo A Corral
1From the Laboratório de Investigação Médica (LIM-06), Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo.
Background:
Strongyloides stercoralis is a parasite that causes human strongyloidiasis. The disease ranges from asymptomatic to severe forms, which are often fatal in immunocompromised individuals. Laboratory diagnosis is challenging owing to limitations in the use of conventional parasitological techniques. The present study aimed to evaluate the indirect immunofluorescence assay (IFA) using infective larvae of S. venezuelensis as an antigen for the immunodiagnosis of human strongyloidiasis in immunocompromised patients.
Methods:
Serum and stool samples from 200 immunocompromised patients (HIV-positive, HTLV-1-positive, and renal, liver, and/or bone marrow transplantation candidates) were used. Stool samples were examined using three parasitological methods: Lutz, Rugai, and culture agar plate. IFA was performed using sections of infective larvae of S. venezuelensis as antigens, and showed 95.4% sensitivity and 95.8% and specificity.
Results:
Among the 200 patients, 17 (8.5%) were positive for S. stercoralis by at least one parasitological method, and 43 (21.5%) were positive by IFA.
Conclusions:
IFA can be used as a screening method for the detection of S. stercoralis in immunocompromised patients.
